CCCC EPS Estimates
C4 Therapeutics, Inc.
$2.61
-$0.17(-6.12%)
40
Overall
60
Value
18
Tech
44
Quality
Market Cap
$321.10M
Volume
3.09M
52W Range
$1.69 - $5.17
Target Price
$12.86
CCCC EPS estimates: the consensus estimate for C4 Therapeutics, Inc.'s current fiscal year is -$0.85 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CCCC EPS Estimates
- EPS estimate, current quarter
- $-0.21
- EPS estimate, next quarter
- $-0.26
- EPS estimate, current year
- $-0.85
- EPS estimate, next year
- $-1.01
- EPS growth, 3-year
- +21.45%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.27 |
| 2024 | $-1.52 |
| 2023 | $-2.67 |
| 2022 | $-2.62 |
| 2021 | $-1.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CCCC | $2.61 | -6.1% | 3.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |